← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

The Chemours Company (CC) 10-Year Financial Performance & Capital Metrics

CC • • Industrial / General
Basic MaterialsSpecialty ChemicalsPerformance Coatings & PaintsIndustrial & Automotive Coatings
AboutThe Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.Show more
  • Revenue $5.78B -4.9%
  • EBITDA $744M +304.3%
  • Net Income $86M +136.1%
  • EPS (Diluted) 0.57 +135.6%
  • Gross Margin 19.91% -7.4%
  • EBITDA Margin 12.87% +325.0%
  • Operating Margin 7.66% +478.6%
  • Net Margin 1.49% +138.0%
  • ROE 12.8% +149.6%
  • ROIC 8.22% +444.0%
  • Debt/Equity 7.20 +23.7%
  • Interest Coverage 1.68 +383.8%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗High debt to equity ratio of 7.2x
  • ✗Negative free cash flow
  • ✗Dividend payout exceeds 100% of earnings

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-1.06%
5Y0.91%
3Y-3.05%
TTM0.74%

Profit (Net Income) CAGR

10Y-14.25%
5Y-
3Y-47.9%
TTM-582.61%

EPS CAGR

10Y-12.59%
5Y-
3Y-45.9%
TTM-669.59%

ROCE

10Y Avg9.73%
5Y Avg7.82%
3Y Avg6.44%
Latest7.72%

Peer Comparison

Industrial & Automotive Coatings
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
CCThe Chemours Company2.33B15.5627.30-4.87%-5.67%-111%7.20
AXTAAxalta Coating Systems Ltd.7.17B33.6118.881.77%8.81%19.57%6.08%1.80
KROKronos Worldwide, Inc.636.24M5.537.3713.24%-2.22%-5.13%6.76%0.65

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+5.72B5.4B6.18B6.64B5.53B4.97B6.34B6.83B6.08B5.78B
Revenue Growth %-0.11%-0.06%0.14%0.07%-0.17%-0.1%0.28%0.08%-0.11%-0.05%
Cost of Goods Sold+4.76B4.29B4.43B4.67B4.46B3.9B4.96B5.21B4.77B4.63B
COGS % of Revenue0.83%0.79%0.72%0.7%0.81%0.79%0.78%0.76%0.79%0.8%
Gross Profit+955M1.11B1.75B1.97B1.06B1.07B1.38B1.62B1.31B1.15B
Gross Margin %0.17%0.21%0.28%0.3%0.19%0.21%0.22%0.24%0.21%0.2%
Gross Profit Growth %-0.3%0.16%0.58%0.12%-0.46%0%0.29%0.17%-0.19%-0.12%
Operating Expenses+729M1.01B682M739M616M619M707M830M1.43B708M
OpEx % of Revenue0.13%0.19%0.11%0.11%0.11%0.12%0.11%0.12%0.24%0.12%
Selling, General & Admin632M934M602M657M00592M710M1.29B585M
SG&A % of Revenue0.11%0.17%0.1%0.1%--0.09%0.1%0.21%0.1%
Research & Development97M80M80M82M80M93M107M118M108M109M
R&D % of Revenue0.02%0.01%0.01%0.01%0.01%0.02%0.02%0.02%0.02%0.02%
Other Operating Expenses0000536M526M8M2M31M14M
Operating Income+226M96M1.07B1.23B447M448M674M786M-123M443M
Operating Margin %0.04%0.02%0.17%0.19%0.08%0.09%0.11%0.12%-0.02%0.08%
Operating Income Growth %-0.58%-0.58%10.17%0.15%-0.64%0%0.5%0.17%-1.16%4.6%
EBITDA+493M380M1.34B1.52B715M768M991M1.08B184M744M
EBITDA Margin %0.09%0.07%0.22%0.23%0.13%0.15%0.16%0.16%0.03%0.13%
EBITDA Growth %-0.38%-0.23%2.54%0.13%-0.53%0.07%0.29%0.09%-0.83%3.04%
D&A (Non-Cash Add-back)267M284M273M284M268M320M317M291M307M301M
EBIT226M208M1.13B1.26B447M447M861M904M-110M391M
Net Interest Income+-132M-219M-214M-195M-208M-210M-185M-163M-208M-264M
Interest Income0000000000
Interest Expense132M219M215M195M208M210M185M163M208M264M
Other Income/Expense-414M-107M-160M-77M-427M-269M2M-45M-195M-316M
Pretax Income+-188M-11M912M1.16B20M179M676M741M-318M127M
Pretax Margin %-0.03%-0%0.15%0.17%0%0.04%0.11%0.11%-0.05%0.02%
Income Tax+-98M-18M165M159M72M-40M68M163M-81M41M
Effective Tax Rate %0.48%-0.64%0.82%0.86%-2.6%1.22%0.9%0.78%0.75%0.68%
Net Income+-90M7M746M995M-52M219M608M578M-238M86M
Net Margin %-0.02%0%0.12%0.15%-0.01%0.04%0.1%0.08%-0.04%0.01%
Net Income Growth %-1.23%1.08%105.57%0.33%-1.05%5.21%1.78%-0.05%-1.41%1.36%
Net Income (Continuing)-90M7M747M996M-52M219M608M578M-237M86M
Discontinued Operations0000000000
Minority Interest4M4M5M6M6M2M1M02M1M
EPS (Diluted)+-0.500.043.915.45-0.321.323.603.65-1.600.57
EPS Growth %-1.23%1.08%96.75%0.39%-1.06%5.13%1.73%0.01%-1.44%1.36%
EPS (Basic)-0.500.044.045.62-0.321.333.693.72-1.600.58
Diluted Shares Outstanding180.99M183.42M190.98M182.57M164.82M166.35M168.7M158.3M148.91M150.01M
Basic Shares Outstanding180M181.62M184.84M176.97M164.82M164.68M164.94M155.36M148.91M149.49M
Dividend Payout Ratio-3.14%0.03%0.15%-0.75%0.27%0.27%-1.72%

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+2.3B2.55B3.49B3.29B2.78B2.63B3.35B3.21B3.83B3.03B
Cash & Short-Term Investments366M902M1.56B1.2B943M1.1B1.45B1.1B1.2B713M
Cash Only366M902M1.56B1.2B943M1.1B1.45B1.1B1.2B713M
Short-Term Investments0000000000
Accounts Receivable859M807M919M861M674M511M720M626M610M770M
Days Sales Outstanding54.8454.5554.2547.3444.5237.5441.4233.4536.6348.61
Inventory972M767M935M1.15B1.08B939M1.1B1.4B1.35B1.47B
Days Inventory Outstanding74.565.2677.0589.7188.2487.8480.8198.27103.41116.02
Other Current Assets104M77M83M84M078M082M705M71M
Total Non-Current Assets+4B3.51B3.8B4.07B4.48B4.45B4.21B4.43B4.42B4.49B
Property, Plant & Equipment3.18B2.78B3.01B3.29B3.85B3.71B3.38B3.41B3.48B3.44B
Fixed Asset Turnover1.80x1.94x2.06x2.02x1.43x1.34x1.88x2.00x1.75x1.68x
Goodwill166M153M153M153M153M153M102M102M102M46M
Intangible Assets10M17M13M28M21M14M6M13M3M3M
Long-Term Investments136M136M173M160M162M167M169M175M158M152M
Other Non-Current Assets461M376M413M391M252M310M376M573M374M556M
Total Assets+6.3B6.06B7.29B7.36B7.26B7.08B7.55B7.64B8.25B7.51B
Asset Turnover0.91x0.89x0.85x0.90x0.76x0.70x0.84x0.89x0.74x0.77x
Asset Growth %0.05%-0.04%0.2%0.01%-0.01%-0.02%0.07%0.01%0.08%-0.09%
Total Current Liabilities+1.47B1.77B1.65B1.71B1.54B1.44B1.86B1.89B2.49B1.8B
Accounts Payable945M884M1.07B1.14B901M820M1.14B1.21B1.13B1.12B
Days Payables Outstanding72.4375.2188.5988.9273.6976.783.984.6986.7488.27
Short-Term Debt39M15M15M13M134M21M25M43M51M54M
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K000
Other Current Liabilities293M572M291M342M148M81M440M325M1.13B554M
Current Ratio1.57x1.44x2.12x1.93x1.80x1.83x1.80x1.70x1.54x1.68x
Quick Ratio0.91x1.01x1.55x1.26x1.10x1.17x1.21x0.96x1.00x0.86x
Cash Conversion Cycle56.9144.5942.7148.1359.0848.6738.3347.0353.3176.35
Total Non-Current Liabilities+4.7B4.18B4.78B4.63B5.02B4.83B4.61B4.64B5.03B5.11B
Long-Term Debt3.92B3.53B4.1B3.96B4.03B4B3.72B3.59B3.94B4.02B
Capital Lease Obligations003M2M245M194M179M198M252M227M
Deferred Tax Liabilities234M132M208M217M118M36M49M61M44M35M
Other Non-Current Liabilities542M519M466M448M625M585M656M793M789M824M
Total Liabilities6.17B5.96B6.43B6.34B6.56B6.27B6.47B6.53B7.51B6.91B
Total Debt+3.95B3.54B4.11B3.97B4.47B4.28B3.99B3.88B4.3B4.36B
Net Debt3.59B2.64B2.56B2.77B3.53B3.17B2.54B2.78B3.1B3.64B
Debt / Equity30.42x34.08x4.75x3.89x6.43x5.25x3.68x3.50x5.82x7.20x
Debt / EBITDA8.02x9.33x3.06x2.62x6.25x5.57x4.02x3.60x23.36x5.85x
Net Debt / EBITDA7.28x6.95x1.90x1.83x4.93x4.13x2.56x2.58x16.83x4.90x
Interest Coverage1.71x0.44x4.99x6.32x2.15x2.13x3.64x4.82x-0.59x1.68x
Total Equity+130M104M865M1.02B695M815M1.08B1.11B739M605M
Equity Growth %-0.96%-0.2%7.32%0.18%-0.32%0.17%0.33%0.02%-0.33%-0.18%
Book Value per Share0.720.574.535.594.224.906.416.994.964.03
Total Shareholders' Equity126M100M860M1.01B689M813M1.08B1.11B737M604M
Common Stock2M2M2M2M2M2M2M2M2M2M
Retained Earnings-115M-114M579M1.47B1.25B1.3B1.75B2.17B1.78B1.72B
Treasury Stock00-116M-750M-1.07B-1.07B-1.25B-1.74B-1.81B-1.8B
Accumulated OCI-536M-577M-442M-564M-349M-310M-364M-343M-274M-367M
Minority Interest4M4M5M6M6M2M1M02M1M

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+182M594M639M1.14B650M807M814M755M556M-633M
Operating CF Margin %0.03%0.11%0.1%0.17%0.12%0.16%0.13%0.11%0.09%-0.11%
Operating CF Growth %-0.64%2.26%0.08%0.78%-0.43%0.24%0.01%-0.07%-0.26%-2.14%
Net Income-90M7M747M996M-52M219M608M578M-238M86M
Depreciation & Amortization267M284M273M284M311M320M317M291M307M301M
Stock-Based Compensation17M19M29M24M19M16M34M27M19M15M
Deferred Taxes-198M-111M83M23M-165M-120M-77M20M-158M-27M
Other Non-Cash Items221M196M57M32M399M16M-89M-58M6M44M
Working Capital Changes-27M484M-466M-206M138M356M21M-103M620M-1.05B
Change in Receivables-64M5M-88M47M191M12M-225M91M0-152M
Change in Inventory19M147M-208M-297M116M126M-210M-294M58M-146M
Change in Payables18M332M-170M44M-169M55M281M105M-72M-9M
Cash from Investing+-497M357M-370M-487M-483M-234M220M-284M-229M-353M
Capital Expenditures-519M-338M-411M-498M-481M-267M-277M-307M-370M-360M
CapEx % of Revenue0.09%0.06%0.07%0.08%0.09%0.05%0.04%0.04%0.06%0.06%
Acquisitions----------
Investments----------
Other Investing12M708M39M46M10M6M509M23M141M7M
Cash from Financing+687M-396M353M-993M-419M-449M-554M-686M172M-36M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid-105M-22M-22M-148M-164M-164M-164M-154M-149M-148M
Share Repurchases----------
Other Financing-2.69B7M-18M-58M-21M-134M-9M43M16M17M
Net Change in Cash----------
Free Cash Flow+-337M256M228M642M169M540M537M448M186M-993M
FCF Margin %-0.06%0.05%0.04%0.1%0.03%0.11%0.08%0.07%0.03%-0.17%
FCF Growth %-2.4%1.76%-0.11%1.82%-0.74%2.2%-0.01%-0.17%-0.58%-6.34%
FCF per Share-1.861.401.193.521.033.253.182.831.25-6.62
FCF Conversion (FCF/Net Income)-2.02x84.86x0.86x1.15x-12.50x3.68x1.34x1.31x-2.34x-7.36x
Interest Paid103M208M208M206M204M208M180M164M223M267M
Taxes Paid53M50M79M75M85M78M149M131M54M73M

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)-4.73%5.98%153.97%105.57%-6.06%29.01%64.1%52.81%-25.79%12.8%
Return on Invested Capital (ROIC)4.59%2.23%26.07%25.62%8.37%8.19%13.29%15.71%-2.39%8.22%
Gross Margin16.7%20.56%28.37%29.69%19.24%21.47%21.77%23.66%21.49%19.91%
Net Margin-1.57%0.13%12.07%14.99%-0.94%4.41%9.58%8.46%-3.92%1.49%
Debt / Equity30.42x34.08x4.75x3.89x6.43x5.25x3.68x3.50x5.82x7.20x
Interest Coverage1.71x0.44x4.99x6.32x2.15x2.13x3.64x4.82x-0.59x1.68x
FCF Conversion-2.02x84.86x0.86x1.15x-12.50x3.68x1.34x1.31x-2.34x-7.36x
Revenue Growth-11.12%-5.54%14.5%7.36%-16.75%-10.08%27.69%7.66%-11.02%-4.87%

Revenue by Segment

2015201620172018201920202021202220232024
Titanium Technologies2.39B---2.35B2.4B3.35B3.38B2.68B2.57B
Titanium Technologies Growth-----2.43%39.68%0.75%-20.71%-4.03%
Thermal And Specialized Solutions-----1.1B1.26B1.68B1.82B1.83B
Thermal And Specialized Solutions Growth------13.76%33.65%8.27%0.60%
Advanced Performance Materials-----1.1B1.4B1.62B1.44B1.33B
Advanced Performance Materials Growth------26.54%15.82%-10.82%-8.11%
Others-------116M85M-
Others Growth---------26.72%-
Chemical Solutions1.12B---533M358M336M---
Chemical Solutions Growth------32.83%-6.15%---
Fluoroproducts2.26B---2.65B-----
Fluoroproducts Growth----------
Titanium Dioxide And Other Minerals---3.17B------
Titanium Dioxide And Other Minerals Growth----------
Fluorochemicals-1.09B1.38B1.5B------
Fluorochemicals Growth--26.08%8.64%------
Fluoropolymers-1.17B1.28B1.36B------
Fluoropolymers Growth--8.97%6.97%------
Performance Chemicals And Intermediates-383M306M313M------
Performance Chemicals And Intermediates Growth---20.10%2.29%------
Mining Solutions-262M261M289M------
Mining Solutions Growth---0.38%10.73%------
Royalty---10M------
Royalty Growth----------
Titanium Dioxide-2.36B2.96B-------
Titanium Dioxide Growth--25.13%-------
Sulfur-127M--------
Sulfur Growth----------

Revenue by Geography

2015201620172018201920202021202220232024
North America2.57B2.29B2.25B-----2.7B2.59B
North America Growth--10.97%-1.44%-------4.04%
Asia Pacific1.39B1.31B1.59B-----1.46B1.39B
Asia Pacific Growth--5.60%21.14%-------5.20%
EMEA977M-------1.19B1.14B
EMEA Growth----------4.61%
Latin America777M716M829M-----674M669M
Latin America Growth--7.85%15.78%-------0.74%
European Union---67M41M3M----
European Union Growth-----38.81%-92.68%----
E M E A-1.08B1.51B-------
E M E A Growth--39.32%-------
CANADA140M125M--------
CANADA Growth--10.71%--------

Frequently Asked Questions

Valuation & Price

The Chemours Company (CC) has a price-to-earnings (P/E) ratio of 27.3x. This suggests investors expect higher future growth.

Growth & Financials

The Chemours Company (CC) reported $5.87B in revenue for fiscal year 2024. This represents a 20% decrease from $7.37B in 2012.

The Chemours Company (CC) saw revenue decline by 4.9% over the past year.

The Chemours Company (CC) reported a net loss of $333.0M for fiscal year 2024.

Dividend & Returns

Yes, The Chemours Company (CC) pays a dividend with a yield of 6.34%. This makes it attractive for income-focused investors.

The Chemours Company (CC) has a return on equity (ROE) of 12.8%. This is reasonable for most industries.

The Chemours Company (CC) had negative free cash flow of $12.0M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.